Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Recast will seek to better define scope of EU medtech directives

This article was originally published in RAJ Devices

Executive Summary

One of the key aims of the European Commission in the recast of the medical device directives it is working on is to ensure that there is better clarity than there is at present about which products are and are not regulated under the directives. Areas of focus include products on the borderline with other directives, as well as implantables or other invasive devices without a medical purpose.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC096662

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel